Terms: = Germ cell tumor AND SMARCD1, CRACD1, 6602, ENSG00000066117, Rsc6p, BAF60A, Q96GM5 AND Treatment
2 results:
1. Integrated analysis reveals smarcd1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.
Chen J; Yu N; Ou S; Wang X; Li H; Zhu H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11619-11634. PubMed ID: 37401939
[TBL] [Abstract] [Full Text] [Related]
2. smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma cells via Crosstalk with Notch1.
Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
[TBL] [Abstract] [Full Text] [Related]
